Form 4: Korro Bio Director Acquires Shares in Recent Transaction

Anthony A. Florence, Jr., a director at Korro Bio, Inc., acquired 17,857 shares of common stock at $56 per share on April 22, 2024.

Summary

• On April 22, 2024, Anthony A. Florence, Jr., a director of Korro Bio, Inc., acquired 17,857 shares of common stock.
• The shares were purchased at a price of $56 per share.
• Following the transaction, Mr. Florence indirectly owns 1,090,793 shares through NEA 17 GP, LLC, which manages NEA Partners 17, L.P., the general partner of New Enterprise Associates 17, L.P. ('NEA 17').
• Mr. Florence disclaims beneficial ownership of the securities held by NEA 17, except to the extent of his pecuniary interest.
• The acquisition was made pursuant to a Subscription Agreement dated April 17, 2024.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a standard regulatory filing indicating a transaction. The director's purchase is a mildly positive signal, but the document itself is purely informational.

Positives

• A director's purchase of shares can be seen as a positive signal, indicating confidence in the company's future prospects.

Industry Context

Form 4 filings are standard practice for reporting changes in beneficial ownership by company insiders, providing transparency to the market.

Stakeholder Impact

• The transaction provides information to shareholders regarding insider activity.
• The purchase could be viewed positively by shareholders, potentially increasing confidence in the company.

Key Dates